Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adopted immunochemotherapy using IL-2 and spleen LAK cell--randomized study].

Y Une1, A Kawata, J Uchino

  • 1First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.

Nihon Geka Gakkai Zasshi
|September 1, 1991
PubMed
Summary

Adoptive immunotherapy using autologous spleen-derived lymphokine-activated killer (LAK) cells, combined with IL-2 and adriamycin, significantly reduced hepatocellular carcinoma recurrence after surgery. This spleen LAK-cell therapy shows promise for preventing post-hepatectomy cancer recurrence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the oral and faecal microbiota associated with atopic dermatitis in dogs selected from a purebred Shiba Inu colony.

Letters in applied microbiology·2022
Same author

Low dose antibiotic ingestion potentiates systemic and microbiome changes induced by silver nanoparticles.

NanoImpact·2022
Same author

Gastrointestinal: Superior mesenteric vein aneurysm treated using interventional radiology.

Journal of gastroenterology and hepatology·2022
Same author

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Fatal Salmonellosis in Captive Maras (Dolichotis patagonum) Caused by Salmonella Enteritidis.

Journal of comparative pathology·2017
Same author

Peracute Bacterial Meningitis due to Infection with Klebsiella pneumoniae in Captive-bred Ruffed Lemurs (Varecia variegate).

Journal of comparative pathology·2017

Area of Science:

  • Oncology
  • Immunology
  • Surgical Oncology

Background:

  • Hepatocellular carcinoma (HCC) recurrence post-hepatectomy remains a clinical challenge.
  • Adjuvant therapies are crucial for improving outcomes after liver resection.
  • Autologous immune cell therapies offer a potential strategy for minimizing residual disease.

Purpose of the Study:

  • To evaluate the efficacy and safety of adoptive immunotherapy with autologous spleen-derived lymphokine-activated killer (LAK) cells in preventing HCC recurrence after hepatic resection.
  • To compare the recurrence rates between patients treated with LAK cell immunotherapy plus chemotherapy and those treated with chemotherapy alone.

Main Methods:

  • Thirty HCC patients undergoing hepatic resection were randomized into two groups.
  • Group A received autologous spleen-derived LAK cells cultured with IL-2, intra-arterial adriamycin, and IL-2 injections.

Related Experiment Videos

  • Group B received only intra-arterial adriamycin.
  • LAK cell accumulation was studied in a mouse lung cancer model.

    • Main Results:

    • The recurrence rate in Group A (8.3%) was significantly lower than in Group B (50%).
    • High fever was observed in all patients receiving LAK cell therapy.
    • Experimental studies showed augmented LAK cell accumulation in splenectomized mice with lung cancer.

    Conclusions:

    • Spleen-derived LAK cell adoptive immunotherapy, in conjunction with IL-2 and adriamycin, is an effective and safe adjuvant treatment for reducing HCC recurrence after hepatectomy.
    • This immunotherapy approach holds potential for preventing post-operative cancer relapse.